tradingkey.logo
tradingkey.logo
Pesquisar

908 Devices Inc.

MASS
Adicionar à lista de desejos
6.900USD
-0.400-5.48%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
260.91MValor de mercado
PerdaP/L TTM

Mais detalhes de 908 Devices Inc. Empresa

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

Informações de 908 Devices Inc.

Código da empresaMASS
Nome da Empresa908 Devices Inc
Data de listagemDec 18, 2020
CEOKnopp (Kevin J)
Número de funcionários246
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 18
Endereço44 Third Avenue
CidadeBURLINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01803
Telefone19787294478
Sitehttps://908devices.com/
Código da empresaMASS
Data de listagemDec 18, 2020
CEOKnopp (Kevin J)

Executivos da empresa 908 Devices Inc.

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.34M
--
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
925.56K
-2.16%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
75.26K
--
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
--
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
--
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Mr. John Kenneweg
Mr. John Kenneweg
Vice President - Government
Vice President - Government
--
--
Mr. Joseph H. (Joe) Griffith, IV
Mr. Joseph H. (Joe) Griffith, IV
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Michael Scott Turner, J.D.
Mr. Michael Scott Turner, J.D.
Chief Legal and Administrative Officer, Company Secretary
Chief Legal and Administrative Officer, Company Secretary
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.34M
--
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
925.56K
-2.16%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
75.26K
--
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
--
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
--
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Device sales revenue
36.66M
65.23%
Recurring revenue
19.42M
34.56%
Contract revenue
117.00K
0.21%
Por RegiãoUSD
Nome
Receita
Proporção
United States
41.25M
73.40%
Europe,Middle East & Africa
10.43M
18.55%
Asia Pacific
3.00M
5.33%
Americas other
1.52M
2.71%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Device sales revenue
36.66M
65.23%
Recurring revenue
19.42M
34.56%
Contract revenue
117.00K
0.21%

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ARCH Venture Partners
15.14%
First Light Asset Management, LLC
12.79%
ARK Investment Management LLC
5.15%
BlackRock Institutional Trust Company, N.A.
4.37%
Knopp (Kevin J)
3.54%
Outro
59.02%
Investidores
Investidores
Proporção
ARCH Venture Partners
15.14%
First Light Asset Management, LLC
12.79%
ARK Investment Management LLC
5.15%
BlackRock Institutional Trust Company, N.A.
4.37%
Knopp (Kevin J)
3.54%
Outro
59.02%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
28.01%
Investment Advisor
23.04%
Venture Capital
15.20%
Individual Investor
8.95%
Hedge Fund
3.93%
Pension Fund
0.93%
Research Firm
0.76%
Bank and Trust
0.11%
Insurance Company
0.03%
Outro
19.04%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
247
28.68M
75.86%
-11.07M
2025Q4
230
33.42M
92.33%
-4.73M
2025Q3
224
29.28M
81.15%
-3.78M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
ARCH Venture Partners
5.73M
15.32%
--
--
Apr 17, 2025
First Light Asset Management, LLC
4.84M
12.94%
+155.33K
+3.32%
Dec 31, 2025
ARK Investment Management LLC
1.99M
5.31%
+32.21K
+1.65%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.65M
4.42%
+56.15K
+3.52%
Dec 31, 2025
Knopp (Kevin J)
1.34M
3.58%
+73.23K
+5.79%
Feb 02, 2026
Brown (Christopher D)
985.56K
2.64%
+23.44K
+2.44%
Feb 01, 2026
Needham Investment Management L.L.C.
770.00K
2.06%
+548.00K
+246.85%
Dec 31, 2025
Geode Capital Management, L.L.C.
688.57K
1.84%
+16.48K
+2.45%
Dec 31, 2025
First Eagle Investment Management, L.L.C.
623.88K
1.67%
+19.92K
+3.30%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ARK Genomic Revolution ETF
1.43%
State Street SPDR S&P Kensho Future Security ETF
0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
0.5%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver Mais
ARK Genomic Revolution ETF
Proporção1.43%
State Street SPDR S&P Kensho Future Security ETF
Proporção0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
Proporção0.5%
iShares Micro-Cap ETF
Proporção0.04%
Avantis US Small Cap Equity ETF
Proporção0.02%
iShares Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
iShares Russell 2000 Growth ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI